AUROBINDO PHARMA
Quarterly Results Analysis [Jun2026]
AUROBINDO PHARMA Quarterly Results
| Consolidated | Jun2026 UnAudited |
Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹9,150 Cr | ₹8,853 Cr | ₹8,646 Cr | ₹8,286 Cr | ₹7,868 Cr | ₹8,382 Cr | ₹7,979 Cr | ₹7,796 Cr |
| Expenses | ₹7,269 Cr | ₹7,101 Cr | ₹6,873 Cr | ₹6,608 Cr | ₹6,265 Cr | ₹6,590 Cr | ₹6,401 Cr | ₹6,230 Cr |
| Operating Income | ₹1,881 Cr | ₹1,753 Cr | ₹1,773 Cr | ₹1,678 Cr | ₹1,603 Cr | ₹1,792 Cr | ₹1,578 Cr | ₹1,566 Cr |
| Other Income | ₹264 Cr | ₹117 Cr | ₹188 Cr | ₹121 Cr | ₹105 Cr | ₹135 Cr | ₹157 Cr | ₹136 Cr |
| Interest | ₹102 Cr | ₹98 Cr | ₹93 Cr | ₹95 Cr | ₹98 Cr | ₹115 Cr | ₹118 Cr | ₹113 Cr |
| Depreciation | ₹487 Cr | ₹479 Cr | ₹465 Cr | ₹429 Cr | ₹406 Cr | ₹444 Cr | ₹419 Cr | ₹382 Cr |
| Profit Before Tax | ₹1,517 Cr | ₹1,293 Cr | ₹1,338 Cr | ₹1,274 Cr | ₹1,205 Cr | ₹1,367 Cr | ₹1,198 Cr | ₹1,207 Cr |
| Profit After Tax | ₹1,034 Cr | ₹923 Cr | ₹909 Cr | ₹846 Cr | ₹822 Cr | ₹935 Cr | ₹844 Cr | ₹817 Cr |
| EPS | ₹17.95 | ₹15.86 | ₹15.67 | ₹14.61 | ₹14.20 | ₹15.56 | ₹14.56 | ₹14.07 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AUROBINDO PHARMA | 1% | 4.6% | 53.3% |
| SUN PHARMACEUTICAL INDUSTRIES | NA | -3.9% | 17.3% |
| DIVIS LABORATORIES | 5% | 21.5% | 44.5% |
| TORRENT PHARMACEUTICALS | -2.1% | -0.2% | 34.3% |
| CIPLA | -2% | -2.5% | -8.1% |
| DR REDDYS LABORATORIES | 0.4% | 4.5% | -4.4% |
| MANKIND PHARMA | 0.3% | -8.6% | -5.5% |
| LUPIN | -0.5% | -8.5% | 12.1% |
| ZYDUS LIFESCIENCES | 3.5% | 4.4% | 15% |
AUROBINDO PHARMA Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 3.35 % |
| Y-o-Y | 16.30 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Jun2026 | ₹9,150 Cr | 3.35 | |
| Mar2026 | ₹8,853 Cr | 2.40 | |
| Dec2025 | ₹8,646 Cr | 4.35 | |
| Sep2025 | ₹8,286 Cr | 5.31 | |
| Jun2025 | ₹7,868 Cr | -6.13 | |
| Mar2025 | ₹8,382 Cr | 5.06 | |
| Dec2024 | ₹7,979 Cr | 2.34 | |
| Sep2024 | ₹7,796 Cr | - | |
AUROBINDO PHARMA Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 7.32 % |
| Y-o-Y | 17.34 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Jun2026 | ₹1,881 Cr | 7.32 | |
| Mar2026 | ₹1,753 Cr | -1.16 | |
| Dec2025 | ₹1,773 Cr | 5.68 | |
| Sep2025 | ₹1,678 Cr | 4.68 | |
| Jun2025 | ₹1,603 Cr | -10.54 | |
| Mar2025 | ₹1,792 Cr | 13.56 | |
| Dec2024 | ₹1,578 Cr | 0.76 | |
| Sep2024 | ₹1,566 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 3.84 % |
| Y-o-Y | 0.93 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Jun2026 | 20.56% | 3.84 | |
| Mar2026 | 19.8% | -3.46 | |
| Dec2025 | 20.51% | 1.28 | |
| Sep2025 | 20.25% | -0.59 | |
| Jun2025 | 20.37% | -4.72 | |
| Mar2025 | 21.38% | 8.09 | |
| Dec2024 | 19.78% | -1.54 | |
| Sep2024 | 20.09% | - | |
AUROBINDO PHARMA Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 11.95 % |
| Y-o-Y | 25.70 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Jun2026 | ₹1,034 Cr | 11.95 | |
| Mar2026 | ₹923 Cr | 1.52 | |
| Dec2025 | ₹909 Cr | 7.44 | |
| Sep2025 | ₹846 Cr | 2.94 | |
| Jun2025 | ₹822 Cr | -12.06 | |
| Mar2025 | ₹935 Cr | 10.79 | |
| Dec2024 | ₹844 Cr | 3.35 | |
| Sep2024 | ₹817 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 8.34 % |
| Y-o-Y | 8.13 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Jun2026 | 11.3 % | 8.34 | |
| Mar2026 | 10.43 % | -0.86 | |
| Dec2025 | 10.52 % | 2.94 | |
| Sep2025 | 10.22 % | -2.20 | |
| Jun2025 | 10.45 % | -6.28 | |
| Mar2025 | 11.15 % | 5.39 | |
| Dec2024 | 10.58 % | 0.95 | |
| Sep2024 | 10.48 % | - | |
AUROBINDO PHARMA Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 13.18 % |
| Y-o-Y | 26.41 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Jun2026 | ₹17.95 | 13.18 | |
| Mar2026 | ₹15.86 | 1.21 | |
| Dec2025 | ₹15.67 | 7.26 | |
| Sep2025 | ₹14.61 | 2.89 | |
| Jun2025 | ₹14.2 | -8.74 | |
| Mar2025 | ₹15.56 | 6.87 | |
| Dec2024 | ₹14.56 | 3.48 | |
| Sep2024 | ₹14.07 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD